메뉴 건너뛰기
Hautarzt
Volumn 56, Issue 5, 2005, Pages 478-479
Discussion on clofazimine;Clofazimin: Aktueller stand der therapie mit Lampren® bei lepra, erythema leprosum und anderen dermatosen nach abgabe des medikamentes von Novartis an die WHO
Author keywords

[No Author keywords available]
Indexed keywords

CLOFAZIMINE;
EID: 20144367626     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-005-0945-2     Document Type: Note
Times cited : (2)
References (4)
  • 1
    • 6344272488 scopus 로고    scopus 로고
    • A comparative study between 12 and 24-dose therapeutic regimens for multibacillary leprosy patients (2004)
    • Sales AM, Sabroza PC, da Costa Nery JA et al. (2004) A comparative study between 12 and 24-dose therapeutic regimens for multibacillary leprosy patients (2004). Int J Lepr Other Mycobact Dis 72:320-323
    • (2004) Int J Lepr Other Mycobact Dis , vol.72 , pp. 320-323
    • Sales, A.M.1    Sabroza, P.C.2    Da Costa Nery, J.A.3
  • 2
    • 20144370764 scopus 로고    scopus 로고
    • Cyclosporin A bei Pyoderma gangraenosum und Vaskulitiden
    • Mrowietz U (Hrsg). Thieme, Stuttgart
    • Sunderkötter C, Bonsmann G (2003) Cyclosporin A bei Pyoderma gangraenosum und Vaskulitiden. In: Mrowietz U (Hrsg) Cyclosporin in der Dermatologie. Thieme, Stuttgart, S 29-37
    • (2003) Cyclosporin in der Dermatologie , pp. 29-37
    • Sunderkötter, C.1    Bonsmann, G.2
  • 3
    • 0343938878 scopus 로고    scopus 로고
    • A new therapeutic approach to type II leprosy reaction
    • Welsh O, Gomez M, Mancias C et al. (1999) A new therapeutic approach to type II leprosy reaction. Int J Dermatol 38:931-933
    • (1999) Int J Dermatol , vol.38 , pp. 931-933
    • Welsh, O.1    Gomez, M.2    Mancias, C.3
  • 4
    • 20144363398 scopus 로고    scopus 로고
    • WHO (1998) WHO Expert Committee on Leprosy. TRS 874, Geneva
    • WHO (1998) WHO Expert Committee on Leprosy. TRS 874, Geneva

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.